Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SNTI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSenti Biosciences announces holding company reorganization, 1-for-1 share conversion by April 16
Filed April 1, 2026 · Period ending April 1, 2026 · ~1 min read
Key Changes
-
high
Shareholders will automatically receive one share of new parent company Senti Biosciences Holdings for each existing share, with identical rights and no action required. Stock continues trading on Nasdaq under ticker SNTI.
Item 8.01 verify on EDGAR → -
medium
Reorganization structured as tax-free transaction for U.S. federal income tax purposes, meaning shareholders will not recognize gains or losses on the automatic share conversion.
Item 8.01 verify on EDGAR → -
medium
Company may cancel or delay the reorganization beyond April 16, 2026 target date. Transaction does not require shareholder vote under Delaware law Section 251(g).
Item 8.01 verify on EDGAR → -
low
No changes to business operations, management team, board of directors, or assets. All directors and officers retain same roles and responsibilities after reorganization.
Item 8.01 verify on EDGAR →
Summary
Senti Biosciences is creating a new parent holding company structure through a tax-free merger expected to close by April 16, 2026. Each existing share will automatically convert into one share of the new entity, Senti Biosciences Holdings, Inc., with identical rights and preferences. The stock will continue trading on Nasdaq under the same SNTI ticker without interruption, though it will receive a new CUSIP number.
For retail investors, this is primarily a structural change with no impact on day-to-day operations or ownership value. The reorganization requires no shareholder vote or action, and creates no taxable event. The company's business, management team, and board remain unchanged. However, the company has reserved the right to cancel or delay the transaction. Investors should watch for the effective date confirmation around April 16 and any subsequent disclosure explaining the strategic rationale for the holding company structure, which companies typically pursue to facilitate future acquisitions, separate business lines, or create operational flexibility.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Senti Biosciences announced a holding company reorganization effective by April 16, 2026, converting shares 1-for-1 into new parent company stock.
Added in current filing · verify on EDGAR →
On April 1, 2026, Senti Biosciences, Inc. (the “Company”) announced plans to implement a holding company reorganization (the “Holding Company Reorganization”), currently planned to become effective by April 16, 2026, by executing a tax-free merger of the Company with and into Senti Biosciences Merger Sub, Inc., a newly formed Delaware corporation that is a subsidiary of a newly formed Delaware corporation, Senti Holdings, Inc. (“Senti Holdings”). Senti Holdings is a subsidiary of a newly formed Delaware corporation, Senti Biosciences Holdings, Inc. (“Senti Biosciences Holdings”), which is a wholly owned subsidiary of the Company. Upon the effectiveness of the Holding Company Reorganization, Senti Biosciences Holdings would become the successor issuer to the Company.
The company is creating a new parent holding company structure through a tax-free merger, with Senti Biosciences Holdings, Inc. becoming the successor issuer. This reorganization is planned to be effective by April 16, 2026. The transaction will be conducted under Delaware law Section 251(g), which does not require a stockholder vote.
Added in current filing · verify on EDGAR →
Each share of the Company’s common stock, par value $0.0001 per share (“Company Common Stock”), issued and outstanding immediately prior to the Holding Company Reorganization would automatically be converted into an equivalent corresponding share of Senti Biosciences Holdings’ common stock, par value $0.0001 per share (“Holdings Common Stock”), having the same designations, rights, powers and preferences and the qualifications, limitations and restrictions as the corresponding share of Company Common Stock being converted.
Existing shareholders will automatically receive one share of the new holding company for each share they currently own, with identical rights and preferences. The conversion happens automatically without any action required from shareholders. Stock certificates and book-entries will represent the same number of shares in the new entity.
Added in current filing · verify on EDGAR →
The stockholders of the Company would not recognize gain or loss for U.S. federal income tax purposes upon the conversion of their shares of Company Common Stock in the Holding Company Reorganization.
The reorganization is structured as a tax-free transaction for U.S. federal income tax purposes, meaning shareholders will not incur taxable gains or losses. The stock will continue trading on Nasdaq under the same ticker symbol "SNTI" without interruption, though it will receive a new CUSIP number.
Added in current filing · verify on EDGAR →
The Company may determine not to implement the Holding Company Reorganization or the completion of the Holding Company Reorganization could be delayed beyond the currently anticipated timeframe, including for factors beyond the control of the Company.
The company reserves the right to cancel or delay the reorganization beyond the April 16, 2026 target date. This disclosure indicates the transaction is not yet finalized and remains subject to potential changes or abandonment.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify